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Background: Krüppel-like Factor 2 (KLF2) plays an important role in vessel maturation during embryonic
development. In adult mice, KLF2 regulates expression of the tight junction protein occludin, which may allow KLF2
to maintain vascular integrity. Adult tamoxifen-inducible Krüppel-like Factor 4 (KLF4) knockout mice have thickened
arterial intima following vascular injury. The role of KLF4, and the possible overlapping functions of KLF2 and KLF4,
in the developing vasculature are not well-studied.
Results: Endothelial breaks are observed in a major vessel, the primary head vein (PHV), in KLF2−/−KLF4−/−
embryos at E9.5. KLF2−/−KLF4−/− embryos die by E10.5, which is earlier than either single knockout. Gross
hemorrhaging of multiple vessels may be the cause of death. E9.5 KLF2−/−KLF4+/− embryos do not exhibit gross
hemorrhaging, but cross-sections display disruptions of the endothelial cell layer of the PHV, and these embryos
generally also die by E10.5. Electron micrographs confirm that there are gaps in the PHV endothelial layer in E9.5
KLF2−/−KLF4−/− embryos, and show that the endothelial cells are abnormally bulbous compared to KLF2−/− and
wild-type (WT). The amount of endothelial Nitric Oxide Synthase (eNOS) mRNA, which encodes an endothelial
regulator, is reduced by 10-fold in E9.5 KLF2−/−KLF4−/− compared to KLF2−/− and WT embryos. VEGFR2, an eNOS
inducer, and occludin, a tight junction protein, gene expression are also reduced in E9.5 KLF2−/−KLF4−/− compared
to KLF2−/− and WT embryos.
Conclusions: This study begins to define the roles of KLF2 and KLF4 in the embryonic development of blood
vessels. It indicates that the two genes interact to maintain an intact endothelial layer. KLF2 and KLF4 positively
regulate the eNOS, VEGFR2 and occludin genes. Down-regulation of these genes in KLF2−/−KLF4−/− embryos may
result in the observed loss of vascular integrity.
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Vasculogenesis is a dynamic process in mammalian em-
bryonic development. Endothelial precursors, known as
angioblasts, initiate intraembryonic vascular development
by murine embryonic day 7.0 (E7.0) forming a primary
capillary plexus (Reviewed in) [1]. During maturation,* Correspondence: jlloyd@vcu.edu
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reproduction in any medium, provided the orendothelial cells recruit mesenchymal cells or vascular
smooth muscle cell (VSMC) progenitors to the surface
of the vessels, and these cells organize into layers
around the tube to support it (Reviewed in) [2]. By E7.5,
endothelial cells also promote and maintain VSMC
differentiation [3].
Krüppel-like Factor 2 (KLF2) is a zinc finger DNA
binding protein with essential roles in vascular endothelial
biology. The gene is expressed in endothelial cells in the
developing mouse as early as E8.5 [4]. KLF2 knockout
mice die in utero between E10.5 and E14.5, and the time
of death is dependent on the genetic background [4-7].tral Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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viable E11.5 KLF2−/− mice. Kuo et al. generated KLF2
knockout embryos, and concluded that death is due to
hemorrhaging and a lack of integrity in the smooth muscle
layers that surround vessels from around E11.5 [5]. Our
previous studies show that in the absence of KLF2, the
dorsal aortae are abnormal in E10.5 FVB/N mice. The
endothelial cell layer lacks integrity and there are erythroid
cells outside of the aortae [7]. In another study, Wu et al.
showed that KLF2−/− embryos have normal endothelial
cell development, but a failure of mural cells to migrate
around endothelial cells to stabilize blood vessels [8].
Recent findings suggest that KLF2 plays an important role
in endothelial barrier function in adult mice. It positively
regulates expression of the tight junction protein occludin
and modification of myosin light chain that is important
for the integrity of the endothelial layer and to avoid
vascular leakage [9].
Krüppel-like Factor 4 (KLF4) is a member of the
Krüppel-like transcription factor family, and is ~90%
similar to KLF2 in its zinc finger DNA binding domain,
suggesting the factors could have common target se-
quences. KLF4 is expressed in mesenchymal tissue,
endothelium and epithelium by E10.5 [10], and is essen-
tial for skin barrier function during development [11].
KLF4 knockout mice die soon after birth [10]. In
tamoxifen-inducible KLF4−/− adult mice, vascular injury-
induced repression of smooth muscle cell markers is de-
layed, thus indicating that KLF4 controls phenotypic
switching of vascular smooth muscle cells [12-16]. Vascu-
lar abnormalities have not been reported during the early
embryonic development of KLF4−/− mice.
In tissue culture, KLF2 plays a role as a molecular trans-
ducer of fluid shear forces, thus directly or indirectly regu-
lating a number of endothelial genes including endothelial
Nitric Oxide Synthase (eNOS) and endothelin [17]. KLF4
is induced by laminar shear stress in human umbilical vein
endothelial cells (HUVECs) and transactivates the eNOS
and thrombomodulin (TM) promoters. TM and eNOS are
important in vascular tone regulation and maintenance of
intact endothelium [18].
KLF2 and KLF4 are induced by shear stress and activated
by the MEK5/MEF2 signaling pathway. Using genome wide
transcriptional profiling of HUVEC cells overexpressing
KLF2, KLF4 or constitutively active MEK5, it was shown
that ~60% of the genes activated by MEK5 were also regu-
lated by either KLF2 or KLF4. These studies suggest that
there is mechanistic and functional conservation between
KLF2 and KLF4 in vascular endothelial cells [18].
The combined roles of KLF2 and KLF4 have thus far
been studied only in in vitro endothelial models. Because
the two factors are evolutionarily closely related, it was
of interest to determine if they had overlapping roles in
embryonic development. This study shows for the firsttime that there are interactions between the KLF2 and
KLF4 genes during vascular development.
Results
KLF2−/−KLF4−/− embryos show hemorrhaging in the
cranial region
KLF2−/− embryos die between E10.5 and E14.5 [6,7] and
KLF4−/− mice die perinatally [11]. Of the 67 embryos ob-
tained from nine KLF2+/−KLF4+/− matings, at least 4
E10.5 KLF2−/−KLF4−/− embryos were expected to be ob-
tained. However, no live KLF2−/−KLF4−/− embryos were
observed at E10.5, and the necrotic KLF2−/−KLF4−/− em-
bryos that were recovered lacked integrity, and could not
successfully be processed for sectioning. Nevertheless, in
these E10.5 KLF2−/−KLF4−/− embryos, gross hemorrha-
ging was evident in the head and trunk (data not shown),
suggesting that this might be a contributing factor in
their early death. Surprisingly, of the 7 KLF2−/−KLF4+/−
embryos obtained, only one embryo had a beating heart
and the other 6 were not viable. Gross hemorrhaging was
also observed in a majority of these embryos. At E10.5,
KLF2−/− embryos were viable as evidenced by a beating
heart, and did not exhibit gross cranial hemorrhaging.
This thus suggests that the additional loss of one KLF4 al-
lele from KLF2−/− embryos results in the hemorrhaging
phenotype, implying an interaction between the KLF2 and
KLF4 genes.
To further investigate the vascular phenotype of
KLF2−/−KLF4−/− compared to KLF2 and KLF4 single
knockout embryos, macroscopic examination of intact
embryos and light microscopic examination of tissue sec-
tions was performed to assess morphological abnormal-
ities. E9.5 embryos were collected from KLF2+/−KLF4+/−
matings. The expected numbers of all genotypes were
obtained, yielding WT (n = 4), KLF2+/−KLF4+/− (n = 7),
KLF2−/− (n = 3), KLF4−/− (n = 3), KLF2−/−KLF4+/− (n = 4),
KLF2+/−KLF4−/− (n = 3), and KLF2−/−KLF4−/− (n = 3)
embryos. All of the E9.5 KLF2−/−KLF4−/− embryos
were viable, as evidenced by a heartbeat. Cranial hem-
orrhaging was not observed in the WT (Figure 1A),
KLF2−/− (Figure 1B) or KLF4−/− (Figure 1C) embryos.
KLF2−/−KLF4+/− and KLF2+/−KLF4−/− embryos also
did not show gross hemorrhaging (Figure 1D and E).
One of the KLF2−/−KLF4−/− embryos showed gross
hemorrhaging macroscopically, in the cranial region,
beginning rostrally at the level of optic vesicle and ending
caudally at the level of the first branchial arch (Figure 1F).
Gross and microscopic examination confirmed that hem-
orrhaging in E9.5 KLF2−/−KLF4−/− embryos is confined
to the primary head vein (PHV) and the rostral portion of
the anterior cardinal vein, into which the PHV drains.
Bleeding penetrates at some levels, all the way to the
midline infiltrating the supporting cranial mesenchyme,
a precursor tissue to vascular smooth muscle. Gross
Figure 1 Ablation of KLF2 and KLF4 leads to cranial hemorrhaging by E9.5. Light micrographs of E9.5 mouse embryo whole mounts were
taken at 16X magnification. A) WT (n = 4); B) KLF2−/− (n = 3); C) KLF4−/− (n = 3); D) KLF2+/−KLF4−/− (n = 3); E) KLF2−/−KLF4+/− (n = 4) embryos
are grossly normal. F) KLF2−/−KLF4−/− (n = 3) embryos show hemorrhaging and/or enlarged blood vessels in the head region. Arrowhead
indicates hemorrhaging.
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vere and occurs in vessels other than the PHV by E10.5,
consistent with the time of death.
Tissue-sections of the PHV at the level of the optic
vesicle reveal a continuous endothelium in E9.5 WT
(Figure 2A) and KLF2−/− (Figure 2B) embryos. In
KLF2−/−KLF4−/− embryos, there are apparent gaps
between adjoining endothelial cells (Figure 2D). Endo-
thelial disruption of the PHV, which was not evident at
the gross level, is also seen at the microscopic level in
two of the four KLF2−/−KLF4+/− embryos that were
examined (Figure 2C). This phenotype is variable, and
the other two E9.5 KLF2−/−KLF4+/− embryos ap-
peared like wild-type, having no PHV phenotype. The
presence of apparent gaps in the endothelial layer sug-
gests a lack of vascular integrity. No abnormal pheno-
type was seen in KLF2+/−KLF4−/− embryos (data not
shown), suggesting that complete KLF2 ablation is re-
quired for this abnormal vascular phenotype. The fact
that the KLF2−/−KLF4−/− and KLF2−/−KLF4+/− pheno-
types are more severe than KLF2−/− indicates that KLF4
plays a larger role in vascular development than previously
recognized and is complemented by KLF2. Serial tis-
sue sections of entire E9.5 embryos were examinedfor this study, and the abnormal vascular phenotype
in KLF2−/−KLF4−/− and some KLF2−/−KLF4+/− em-
bryos is observed only in the primary head vein. The
primary head vein is one of the major blood vessels at
this stage of development. Although the PHV is the only
vessel to exhibit hemorrhaging at E9.5, based on the
gross hemorrhaging observed by E10.5, other vessels in
KLF2−/−KLF4−/− embryos lack integrity by this later
time point.
Electron micrographs confirm disruption of the
endothelial layer of the primary head vein in
KLF2−/−KLF4−/− embryos at E9.5
The apparent endothelial disruption at the primary
head vein observed in E9.5 KLF2−/−KLF4−/− embryos
was more completely characterized using transmission
electron microscopy (TEM). Electron micrographs of
the PHV at the level of the optic vesicle are shown in
Figure 3. In the WT, the endothelium is continuous
with gaps ≤ 5 μm (Figure 3A). The typical flattened
spindle shape of the endothelial cells seen at the light
level is confirmed. The KLF4−/− embryo also has endo-
thelium that is generally continuous with gaps that are in-
distinguishable from WT (Figure 3B). KLF2−/− embryos
Figure 2 KLF2−/−KLF4−/− primary head vein lacks continuous endothelial layer at E9.5. Light micrographs of 6 μm sections were taken at
200X magnification. A) WT and B) KLF2−/− (n = 4) shows normal looking primary head vein; C) Two of the four KLF2−/−KLF4+/− embryos have
gaps in the endothelial layer of the primary head vein (n = 4); D) KLF2−/−KLF4−/− primary head vein lacks a continuous endothelial layer (n = 3).
Red arrows indicate apparent gaps in the endothelial layer. Black arrows point at the lumen of the Primary Head Vein (PHV).
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PHV has no visible abnormalities of the endothelium,
with gaps appearing identical to the WT and KLF4−/−
embryos (data not shown). Another KLF2−/− shows
multiple ≤ 8 μm gaps along the medial aspect of the ves-
sel (Figure 3C). Endothelial cells are present and outline
the lumen of the PHV. KLF2−/−KLF4−/− embryos have
endothelial disruption and more frequent gaps ≤ 20 μm
on both the medial and lateral aspects of the fragmented
vessel wall (Figure 3D). Furthermore, the endothelial cells
in the KLF2−/−KLF4−/− vessels are more bulbous in
shape compared to KLF2−/−, KLF4−/− and WT. These
findings confirm the disruption of the endothelial layer of
the PHV observed at the light microscopy level in E9.5KLF2−/−KLF4−/− embryos. In all four genotypes tested,
mesenchymal cells are found near the PHV at E9.5, but
muscle cells have not yet formed a continuous layer
surrounding the vessel (Figure 3A-3D).
KLF2 and KLF4 regulate eNOS mRNA expression at E9.5
To begin to elucidate the molecular mechanism by
which KLF2 and KLF4 ablation results in endothelial
disruption, the amounts of mRNA for endothelial cell
regulators were quantified. Genes were selected for
their established role in vascular development, a similar
KO phenotype to KLF2−/−KLF4−/−, the presence of
potential KLF2 and KLF4 binding sites (CCRCCC) in
the proximal promoter [19,20], and a high ratio of
Figure 3 Electron micrographs confirm disruption of the endothelial layer of the primary head vein in E9.5 KLF2−/−KLF4−/− embryos.
Images were taken of the PHV at the level of the optic vesicle. The endothelial cell layer was pseudo-colored using GIMP (GNU Image
Manipulation Program) version 2.6 open-source digital photo editing software. A) WT embryo (n = 1) has a continuous endothelial layer with
slight gaps less than 5 μm in length. B) Only slight gaps were observed in KLF4−/− embryo (n = 1). C) One of the two KLF2−/− embryos
presented a few gaps of 8 μm and 7.5 μm in length. D) KLF2−/−KLF4−/− embryos (n = 2) had consistent disruptions of the endothelial
membrane with gaps as long as 17 μm. PHV: primary head vein lumen: Endo: endothelial cell; Mes: mesenchymal cell.
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at E9.5.
Expression of eNOS mRNA in E9.5 mouse embryos
was quantified and normalized to the ubiquitously-
expressed housekeeping gene, Cyclophilin A (Figure 4).
While no difference in eNOS mRNA expression is
noted between WT and KLF2−/−, eNOS mRNA expres-
sion in KLF2−/−KLF4−/− is significantly lower than in
WT (p = 0.0009), KLF2+/−KLF4+/− (p = 0.0015) and
KLF2−/− (p = 0.0077) embryos using a two-tailed student
t-test. Additionally, using the same statistical test, eNOS
expression in KLF2−/−KLF4+/− is significantly lower than
in WT (p = 0.0008), KLF2+/−KLF4+/− (p = 0.0015) and
KLF2−/− embryos (p = 0.0078) (Figure 4A). Unfortunately,
KLF4−/− embryos were not obtained for the gene expres-
sion studies; we cannot rule out the possibility that KLF4
knockout alone affects endothelial cell gene regulation.
The data indicate that both KLF2 and KLF4 are required
for eNOS regulation. Interestingly, lower eNOS mRNA
expression correlates with the more severe phenotype
in KLF2−/−KLF4+/− and KLF2−/−KLF4−/− embryos
compared to the other genotypes. KLF2 and KLF4 posi-
tively affect the expression of eNOS, which is a regulator
of endothelial homeostasis and vasculogenesis. eNOS−/−
mice are not embryonic lethal and their phenotype is
indistinguishable from eNOS+/− and wild-type mice ingeneral appearance and histology [21]. Thus, other genes
downstream of KLF2 and KLF4 must also contribute to
the embryonic lethality of KLF2−/−KLF4−/−.
VEGFR2 (Figure 4B) and occludin (Figure 4C) mRNA
expression is significantly reduced in KLF2−/−KLF4−/−
and KLF2−/−KLF4+/− embryos compared to WT. The
decrease in these mRNAs is modest (2-fold), however
VEGFR2 and occludin are not endothelial cell-specific,
and their reduction in endothelial cells may be more
pronounced. VEGFR2 induces eNOS expression [22]
and occludin is a tight junction protein [23]. Therefore,
the reduced expression of these genes could logically
contribute to the observed vascular integrity phenotype.
The other genes tested were endothelin-1, throm-
bomodulin-1 and PECAM1. None of these genes
showed significant differences in mRNA expression in
the KLF2−/−KLF4−/− or KLF2−/−KLF4+/− compared
to WT or KLF2−/− embryos. Therefore, it is not likely
that these genes are responsible for the diminished
vascular integrity observed in KLF2−/−KLF4−/− and
KLF2−/−KLF4+/− embryos.
Discussion
At E9.5, KLF2−/−KLF4−/− embryos exhibit variable
macroscopic and uniform microscopic hemorrhaging,
and these are sometimes observed in KLF2−/−KLF4+/−
Figure 4 KLF2 and KLF4 gene ablation decreases eNOS mRNA expression in E9.5 embryos. A) qRT-PCR revealed that eNOS mRNA was
reduced in E9.5 KLF2−/−KLF4+/− and KLF2−/−KLF4−/− embryos compared to KLF2−/− (p = 0.0078 and p = 0.0077, respectively) and WT (p = 0.0008
and p = 0.0009, respectively) embryos of the same age. B) VEGFR2 mRNA is significantly reduced in KLF2−/−KLF4+/− and KLF2−/−KLF4−/−
compared to WT (p = 0.0021 and p = 0.0041, respectively) but not KLF2−/−. C) Occludin mRNA is also significantly reduced in KLF2−/−KLF4+/−
and KLF2−/−KLF4−/− compared to WT (p = 0.0167 and p = 0.011, respectively) and KLF2−/− (p = 0.013 and p = 0.016, respectively). D) Endothelin,
E) Thrombomodulin-1 and F) PECAM1 mRNA amounts are not significantly different in KLF2−/−KLF4−/− and KLF2−/−KLF4+/− compared to WT and
single knockout embryos. n = 3 for each genotype.
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embryos die by E10.5, which is earlier than either sin-
gle knockout. Similarly, KLF1−/−KLF2−/− embryos
also die sooner than either single knockout [24]. The
KFL2−/−KLF4+/− phenotype is more variable and less se-
vere than KLF2−/−KLF4−/−, indicating that the loss of an
additional KLF4 allele negatively impacts mouse embryonic
vascular development. Interestingly, KLF2+/−KLF4−/−
embryos have a less severe phenotype than either
KLF2−/−KLF4+/− or KLF2−/−KLF4−/− embryos, indi-
cating that hemorrhaging at E9.5 occurs only with the
complete loss of KLF2. A similar gene dosage effect is
also evident in double mutant Hoxa-13 and Hoxd-13
mice [25]. Hoxa-13−/−Hoxd-13−/− and Hoxa-13−/−Hoxd-
13+/− mutations are embryonic lethal. Hoxa-13+/−Hoxd-
13−/− mice reach adulthood but have more severe
abnormalities of the genitourinary and digestive systems
than seen in Hoxa-13−/− or Hoxa-13+/−Hoxd-13+/−
double heterozygote mice.
Interestingly, loss of blood vessel integrity is observed
only in the primary head vein in E9.5 KLF2−/−KLF4−/−
embryos. The significance of this observation is somewhat
diminished by the fact that many vessels throughout the
KLF2−/−KLF4−/− embryo exhibit gross hemorrhaging byE10.5, coincident with embryonic demise. The primary
head vein is one of the major blood vessels at E9.5, but
there is no evidence that it is subject to higher fluid shear
force.
The most prominent effect on gene expression that we
observed in KLF2−/−KLF4−/− compared to KLF2−/−
and WT E9.5 embryos is a reduction in eNOS mRNA.
eNOS regulates many processes relevant to vasculogen-
esis, including vasodilation, vascular smooth muscle
tone, and endothelial homeostasis [26]. The roles of
eNOS and nitric oxide in embryonic vascular develop-
ment are less well-studied than in the adult. However,
recently a role for VEGF-mediated regulation of eNOS
in angioblast and embryonic endothelial cell prolifera-
tion has been discovered [27]. In E9.5 eNOS-GFP em-
bryos, GFP can be detected in the vessels supplying the
head, suggesting that eNOS could be expressed in pri-
mary head vein endothelial cells [28]. Blood vessels in
embryos lacking KLF2 and KLF4 might not be able to
withstand increasing fluid shear stress leading to their
disruption, and this could be due in part to a reduction
in eNOS. The lack of vascular integrity observed in
KLF2−/−KLF4−/− embryos in this study is apparently
not due simply to a lack of vascular smooth muscle or
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yet a continuous layer of mesenchymal cells surrounding
the primary head vein at E9.5. Although eNOS can be
dispensable in early embryos, some eNOS−/− embryos
die between E8.5 and E10.5, coincident with the time of
death of KLF2−/−KLF4−/− embryos [29]. In the absence
of KLF2 and KLF4 it is likely that a host of other endo-
thelial regulators are down-regulated, in addition to
eNOS, exacerbating the effect. Occludin and VEGFR2
mRNA are also reduced in E9.5 embryos lacking KLF2
and KLF4. Occludin is a tight junction protein, and its role
in vascular integrity has been established [9]. Complete
ablation of VEGFR2 leads to embryonic lethality and loss
of vessel development [30]. Down-regulation of VEGFR2
in KLF2−/−KLF4−/− mice may further diminish eNOS ex-
pression, because VEGF signaling induces eNOS [27]. The
data suggest that the loss of both KLF2 and KLF4 creates
a situation where eNOS deficiency cannot be compen-
sated, due to disruption of other endothelial regulators,
resulting in loss of vascular integrity.
In cultured HUVEC cells, overexpression of KLF2
positively regulates the eNOS gene [31]. In our study in
E9.5 mouse embryos, eNOS expression is regulated co-
ordinately by KLF2 and KLF4, but is not diminished in
the absence of KLF2 alone. Lee et al. also did not ob-
serve a reduction in eNOS mRNA in KLF2 endothelial
conditional knockout mice at E11.5 [4]. Similarly, when
the KLF2 gene is conditionally deleted in adult mice,
occludin expression is reduced [32], but occludin mRNA
is reduced in KLF2−/−KLF4−/− but not in KLF2−/−
embryos, compared to WT. Evidently, KLF4 can partially
compensate for KLF2 in regulating the eNOS and occlu-
din genes in embryonic vascular endothelial cells, but
not in the adult mouse or in tissue culture systems.
A limitation of this work is the use of knockout mice
lacking expression of KLF2 and KLF4 in all cell types,
rather than just endothelial cells. We cannot rule out the
possibility that a lack of expression of KLF2 or KLF4 in
cells other than endothelial cells may contribute to the
vascular phenotype. For example, in adult mice, KLF2
and KLF4 are expressed in monocytes and macrophages
[33-35]; it is not known if they are expressed in primitive
phagocytes, and whether this could have a role in vascu-
logenesis. Furthermore, KLF4 is expressed in vascular
smooth muscle cells [12], and could potentially be
expressed and have a function in mesenchymal precur-
sors to these cells at E9.5. However, only endothelial
cells are specifically known to express both KLF2 and
KLF4 at E9.5, so the most parsimonious explanation is
that these genes interact in endothelial cells, resulting in
the phenotype exhibited in double mutant embryos. In
the future, a double conditional knockout mouse model
could be used to determine if KLF2 and KLF4 have cell
autonomous roles in the vascular endothelium.Conclusions
This study begins to define the roles of KLF2 and KLF4
in the embryonic development of blood vessels. The two
genes interact to maintain an intact endothelial layer.
KLF2 and KLF4 positively regulate the eNOS, VEGFR2
and occludin genes, and this may be required to establish
or maintain vascular integrity. KLF2 and KLF4 could regu-
late these genes through direct or indirect mechanisms,
and this is a question for future study.
Methods
Animal ethics
The animal experiments were approved by the Virginia
Commonwealth University Institutional Animal Care
and Use Committee, under protocol number AM10347.
Generation of KLF2/KLF4 Mice
The KLF2 KO mouse model was developed by targeting
the KLF2 gene with the hypoxanthine phosphoribosyl-
transferase (Hprt) gene [6]. KLF4 KO mice were produced
using a targeting vector containing a PGK promoter-
driven neomycin gene to delete exons 2, 3, and a portion
of exon 1 through homologous recombination in ES cells
[11]. KLF2 and KLF4 are located on mouse chromosomes
8 and 4, respectively, and therefore segregate independ-
ently in meiosis. KLF2+/− and KLF4+/− mice were bred
to generate KLF2+/−KLF4+/− double heterozygous
mice, which were then bred to generate homozygous
KLF2−/−KLF4−/− double knockout embryos. All em-
bryos were in undefined mixed genetic background with
approximately 50% FVB/N character.
Embryos were transferred to tooled neck glass vials or
cryotubes and either quick-frozen in liquid nitrogen for
analysis via quantitative reverse transcriptase polymerase
chain reaction (qRT-PCR) or fixed for microscopy and
electron microscopy. Tissue quick-frozen in liquid nitro-
gen was stored at −80°C until processing.
Light and electron microscopy
Embryos were fixed in 2% PFA/0.5% glutaraldehyde and
embedded in eponate 12 resin. Plastic-embedded speci-
mens were cut in transverse section (cross-section) at
6 μm thickness on a Sorvall JB4 Microtome. The tissue
sections were stained with a solution composed of 1%
sodium borate, 1% azure II, 1% toluidine, and 1% methy-
lene and photographed with an Olympus DP71 digital
camera, mounted to an Olympus BX41 compound micro-
scope, visualized with Olympus DP Controller 3.2.1.276
imaging software.
For transmission electron microcopy (TEM), thin sec-
tions were cut at 100 nm on a LKB 2128 Ultratome, and
stained with 5% uranyl acetate and Reynold’s lead citrate.
Images were made using a JEOL JEM-1230 TEM and
Gatan Ultrascan 4000 digital camera at 1,000 – 8,000X.
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RNA was prepared from E9.5 whole embryos, and quanti-
tative RT-PCR (qRT-PCR) was performed as previously
described [7]. Primer sequences of the tested genes are as
follows: eNOS 5′-CTGCCACCTGATCCTAACTTG-3′
and 5′-CAGCCAAACACCAAAGTCATG-3′; Endothelin
5′ CCTTAAGGGCCAGTTCAGGT 3′ and 5′ CTCTGC
CAAGGATCGTGTTT 3′; Thrombomodulin-1 5′AAA
CACGATCCTTGGCAGAG 3′ and 5′ CCTAAGGGAGT
CACGTGCAA 3′; VEGFR2 5′ AAACACGATCCTTGG
CAGAG 3′ and 5′ GACTGGCCTAAGGGAGTCAC 3′;
Occludin 5′-CACACTTGCTTGGGACAGAGG-3′ and
5′-TGAGCCGTACATAGATCCAGGAGC-3′; PECAM1
5′ TCCATGTCCCGAGAAGAGCAG 3′ and 5′ GCAGC
GGGGTTTAAAATTG 3′ forward and reverse primers
respectively. The normalized data were scaled by setting
the WTaverage to a value of 100.
Statistical analysis
The Student’s t-test was used for statistical analyses.
Standard deviation was used to measure deviation from
the mean, for all experiments. For all of the statistical
tests, p values ≤ 0.05 were considered significant.
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